Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0RWZVE
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
TW201803600A ADC-2
|
|||||
| Synonyms |
ADC-2
Click to Show/Hide
|
|||||
| Organization |
SEAGEN INC.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2-5
|
|||||
| Structure |
|
|||||
| Antibody Name |
h2H12EC
|
Antibody Info | ||||
| Antigen Name |
Myeloid cell surface antigen CD33 (CD33)
|
Antigen Info | ||||
| Payload Name |
PBD
|
Payload Info | ||||
| Therapeutic Target |
Deoxyribonucleic acid (DNA)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
TW201803600A-ADC-2-linker-PBD
|
|||||